Samia Mora, Dr
Dr. Samia Mora is an Associate Professor of Medicine at Harvard Medical School, Boston, Massachusetts. She is a cardiovascular medicine specialist at the Brigham and Women’s Hospital, where she is the Director of the Center for Lipid Metabolomics, Division of Preventive Medicine. She also has joint appointments in the Divisions of Cardiovascular Medicine, and Women’s Health. Dr. Mora was born in Beirut, Lebanon. She received her undergraduate degree from Harvard University, and her medical degree from Harvard Medical School. She completed an internal medicine residency at Massachusetts General Hospital and a cardiovascular disease fellowship at The Johns Hopkins Hospital, where she also obtained a Masters in Health Science (Epidemiology) from the Johns Hopkins Bloomberg School of Public Health. She is board certified in cardiovascular disease and echocardiography, and is a Fellow of the American Heart Association, American College of Cardiology, and American Society of Echocardiography. She also serves on the Editorial Board of JAMA Internal Medicine.
Dr. Mora’s clinical interests include cardiovascular prevention, lipids, modifiable risk factors, and women’s health. The author of over 90 peer-reviewed publications, Dr. Mora’s research focuses on risk factors and prevention of cardiovascular disease. She is actively involved with several randomized clinical trials and observational studies, having served on the Clinical Coordinating Committee of the JUPITER trial, and currently serves as the Director of Core Biomarker Studies in the VITAminD and OmegA-3 Trial (VITAL).
Børge G. Nordestgaard, MD, DMSc
Chief Physician in Clinical Biochemistry at Copenhagen University Hospital, Denmark
Professor in Genetic Epidemiology at University of Copenhagen, Denmark
In 1985 he graduated as a medical doctor from University of Copenhagen. Scientific education included 2 years with Professor Steen Stender at Copenhagen University Hospital in Denmark, 2 years with Professor Donald Zilversmit at Cornell University in Ithaca, New York, and 2 years with Professor Barry Lewis at St. Thomas’s Hospital in London, UK.
In 1990 he was awarded Doctor of Medical Sciences by University of Copenhagen and in 1996 Specialist in Clinical Biochemistry by the Danish Board of Health. Clinical training includes hyperlipidemia, gastroenterology, internal medicine, cardiology, and clinical biochemistry.
Prof. Nordestgaard has for more than 25 years continued his interest in the pathogenesis, diagnosis and treatment of hyperlipidemia, atherosclerosis and cardiovascular disease, and has written extensively on these conditions in medical textbooks, original articles and in consensus statements. Over the past 20 years he has given numerous talks on how best to treat hyperlipidemia and how to diagnose and prevent atherosclerosis and cardiovascular disease.
In 1988-97 he acted as an Executive Committee member and in 1993-1997 as chairman of the Scandinavian Society for Atherosclerosis Research. In addition, in 1998-01 and in 2013-17 he was/is an Executive Committee member of the European Atherosclerosis Society and in 1999-02 an Executive Scientific Committee member of the European Society of Cardiology. He has organised or co-organised 8 Scandinavian and 7 European conferences, mainly on atherosclerosis and cardiovascular disease in general.
He is chairing the Copenhagen General Population Study and is also a steering committee member of the Copenhagen City Heart Study.
Prof. Børge G. Nordestgaard has supervised 42 Ph.D. students and 20 post doctoral fellows, and has published 485 original articles and 71 reviews, book chapters, consensus statements, & editorials.
Original articles include publications in New England Journal of Medicine, Lancet, Nature, Nature Genetics, Journal of the American Medical Association, British Medical Journal, PLos Medicine, Circulation, Journal of the American College of Cardiology and European Heart Journal.
He is currently on the editorial board of Clinical Chemistry and Journal of Internal Medicine, and is a board member of the Danish Medical Research Council.
Gerlad Watts DSc ,MD, PhD, FRCP, FRACP
Gerald F Watts is a senior consultant physician, university professor and chair of The Familial Hypercholesterolaemia-Australasia Network. He is director of the Metabolic Research Centre, Cardiometabolic Services and Head of the School of Medicine and Pharmacology Unit (University of Western Australia) and Professor of Cardiometabolic Medicine at Royal Perth Hospital. Research interests include lipid disorders, obesity and cardiovascular prevention, and clinical interest focuses on delivering improved health care for FH. Professor Watts is actively involved in teaching and supervisors PhD students and post-doctoral fellows. He has authored over 500 published works and is on the editorial board of Atherosclerosis, Clinical Science, Metabolism, Journal of Clinical Lipidology, and Current Opinion in Lipidology.
Δείτε το πρόγραμμα του 3ου Εκπαιδευτικού Σεμιναρίου ΕΚΘΑ